Expression and structural properties of a chimeric protein based on the ectodomains of E1 and E2 hepatitis C virus envelope glycoproteins.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Protein Expression and Purification

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.pep.2010.02.012PMID 20176110
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural properties of the ectodomain of hepatitis C virus E2 envelope protein.

  2009cited by this paper
• Structural characterisation of the hepatitis C envelope glycoprotein E1 ectodomain derived from a mammalian and a yeast expression system.

  2008cited by this paper
• Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins

  2007cited by this paper
• Flaviviridae :T he Viruses and Their Replication

  2007cited by this paper
• Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

  2007cited by this paper
• Hepatitis C virus entry into host cells

  2007cited by this paper
• The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

  2007cited by this paper
• Hepatitis C Viruses

  2006cited by this paper
• Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

  2006cited by this paper
• Purification and application of bacterially expressed chimeric protein E1E2 of hepatitis C virus.

  2006cited by this paper
• Cell entry of hepatitis C virus.

  2006cited by this paper
• Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus.

  2006cited by this paper
• High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI*

  2006cited by this paper
• Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeast.

  2006cited by this paper
• Mechanism of action of interferon and ribavirin in treatment of hepatitis C

  2005cited by this paper
• Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

  2005cited by this paper
• An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

  2005cited by this paper
• Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins.

  2005cited by this paper
• Robust hepatitis C virus infection in vitro.

  2005cited by this paper
• Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Glycoproteins

  2005cited by this paper
• Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2.

  2005cited by this paper
• Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells.

  2005cited by this paper
• Characterization of Functional Hepatitis C Virus Envelope Glycoproteins

  2004cited by this paper
• Hepatitis C Virus E2 Has Three Immunogenic Domains Containing Conformational Epitopes with Distinct Properties and Biological Functions

  2004cited by this paper
• Human Monoclonal Antibody to Hepatitis C Virus E1 Glycoprotein That Blocks Virus Attachment and Viral Infectivity

  2004cited by this paper
• Characterisation of bacterially expressed structural protein E2 of hepatitis C virus.

  2004cited by this paper
• Coexpression of Hepatitis C Virus E1 and E2 Chimeric Envelope Glycoproteins Displays Separable Ligand Sensitivity and Increases Pseudotype Infectious Titer

  2004cited by this paper
• Glycosylation of hepatitis C virus envelope proteins.

  2003cited by this paper
• Recognition of Native Hepatitis C Virus E1E2 Heterodimers by a Human Monoclonal Antibody

  2003cited by this paper
• In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

  2003cited by this paper
• Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes

  2003cited by this paper
• Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

  2003cited by this paper
• Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells.

  2002cited by this paper
• Recombinant Carp Parvalbumin, the Major Cross-Reactive Fish Allergen: A Tool for Diagnosis and Therapy of Fish Allergy1

  2002cited by this paper
• Interaction of Hepatitis C Virus-Like Particles and Cells: a Model System for Studying Viral Binding and Entry

  2002cited by this paper
• Reconstitution of Hepatitis C Virus Envelope Glycoproteins into Liposomes as a Surrogate Model to Study Virus Attachment*

  2002cited by this paper
• Intracellular functions of N-linked glycans.

  2001cited by this paper
• Biogenesis of hepatitis C virus envelope glycoproteins.

  2001cited by this paper
• Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.

  2001cited by this paper
• Characterization of pseudotype VSV possessing HCV envelope proteins.

  2001cited by this paper
• Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

  2000cited by this paper
• Folding, assembly and subcellular localization of hepatitis C virus glycoproteins.

  2000cited by this paper
• Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding.

  2000cited by this paper
• Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection.

  1999cited by this paper
• Comparison of secretion of a hepatitis C virus glycoprotein in Saccharomyces cerevisiae and Kluyveromyces lactis.

  1999cited by this paper
• Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties.

  1998cited by this paper
• Functional Role of Hepatitis C Virus Chimeric Glycoproteins in the Infectivity of Pseudotyped Virus

  1998cited by this paper
• Characterization of the structural proteins of hepatitis C virus expressed by an adenovirus recombinant.

  1998cited by this paper
• Hepatitis C Virus Structural Proteins Assemble into Viruslike Particles in Insect Cells

  1998cited by this paper
• Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening.

  1997cited by this paper
• Formation of native hepatitis C virus glycoprotein complexes

  1997cited by this paper
• Characterization of truncated forms of hepatitis C virus glycoproteins.

  1997cited by this paper
• A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.

  1996cited by this paper
• Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa

  1996cited by this paper
• GOR method for predicting protein secondary structure from amino acid sequence.

  1996cited by this paper
• Purification and in vitro-phospholabeling of secretory envelope proteins E1 and E2 of hepatitis C virus expressed in insect cells.

  1996cited by this paper
• Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin

  1996cited by this paper
• Vaccination of chimpanzees against infection by the hepatitis C virus.

  1994cited by this paper
• Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses

  1994cited by this paper
• Expression and identification of hepatitis C virus polyprotein cleavage products

  1993cited by this paper
• Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses

  1993cited by this paper
• Deconvolution of the circular dichroism spectra of proteins: The circular dichroism spectra of the antiparallel β‐sheet in proteins

  1992cited by this paper
• Convex constraint analysis: a natural deconvolution of circular dichroism curves of proteins.

  1991cited by this paper
• Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.

  1991cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens

  2021cites this paper
• From Structural Studies to HCV Vaccine Design

  2021cites this paper
• HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development

  2020cites this paper
• Expression and Purification of Recombinant Mayaro Virus Envelope Glycoproteins E1 and E2 to Develop a Mayaro Virus Detection System

  2020cites this paper
• The deletion of residues 268-292 of E1 impairs the ability of HCV envelope proteins to induce pore formation.

  2016cites this paper
• Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex

  2016cites this paper
• Isolation, cloning and co-expression of hepatitis C virus envelope proteins: as potential HCV detecting antigens.

  2015cites this paper
• High-yield production of a chimeric glycoprotein based on permuted E1 and E2 HCV envelope ectodomains.

  2015influential citation
• Involvement of loops 2 and 3 of α-sarcin on its ribotoxic activity.

  2015cites this paper
• Recombinant hepatitis C virus-envelope protein 2 interactions with low-density lipoprotein/CD81 receptors

  2015cites this paper
• A Single-Step Purification of the Glycoprotein of Nipah Virus Produced in Insect Cells using an Anion Exchange Chromatography Method

  2014cites this paper
• Production and characterization of the ectodomain of E2 envelope glycoprotein of hepatitis C virus folded in the presence of full-length E1 glycoprotein.

  2014cites this paper
• Fusogenic properties of the ectodomains of hepatitis C virus envelope proteins

  2014cites this paper
• Interaction of a chimeric protein based on the ectodomains of E 1 and E 2 hepatitis C virus envelope glycoproteins with phospholipid vesicles

  2013cites this paper
• Fungal extracellular ribotoxins as insecticidal agents.

  2013cites this paper
• Interação da proteina e2 do vírus da hepatite c com o receptor de ldl e cd81 presentes em células endoteliais e ativação da resposta inflamatória

  2012cites this paper
• Factors affecting recombinant Western equine encephalitis virus glycoprotein production in the baculovirus system.

  2011cites this paper